Skip to content

Haemonetics HAE Gross margin

Gross margin at other companies

Abbott logo
AbbottABT
56.3%+0.4pp
TFX
TeleflexTFX
38.2%-3.0pp
Boston Scientific logo
Boston ScientificBSX
69.2%+0.5pp
Medtronic logo
MedtronicMDT
65%-0.3pp
LivaNova logo
LivaNovaLIVN
67.5%-0.5pp
ICU Medical logo
ICU MedicalICUI
37.9%+2.8pp

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.37B-18.0%
Enterprise value$4.4B-12.5%
P/S2.5×-0.5×

Profitability

See full
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Calculated from Haemonetics’s reported figures.

Based on trailing twelve months.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's gross margin?
Haemonetics (HAE) reported gross margin of 59% in Q1 2026.
How has Haemonetics's gross margin changed year-over-year?
Haemonetics's gross margin increased by 7.3% year-over-year, from 55% to 59%.
What is the long-term trend for Haemonetics's gross margin?
Over 5 years (2021 to 2026), Haemonetics's gross margin has grown at a 5.3% compound annual growth rate (CAGR), from 45.7% to 59%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.